About Dana Solutions
Dana Solutions is a company based in Palo Alto (United States) founded in 2018 was acquired by Curi Bio in July 2020. Dana Solutions operates in a competitive market with competitors including Insitro, Certara, HotSpot Therapeutics, CytoReason and GRO Biosciences, among others.
- Headquarter Palo Alto, United States
- SectorsHealthcare
- Website danasolutionsllc.com
- Social LinkedIn X
- Acquired by Curi Bio (Jul 2020)
Investors in Dana Solutions
Dana Solutions has secured backing from 1 investor. Prominent investors backing the company include Curi Bio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drugs for multiple therapeutic areas are manufactured by Curi Bio. | 2015 | curibio.com | Seattle, United States |
Investor details for Dana Solutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dana Solutions
1 people are tracked at Dana Solutions (1 in leadership).
| Name | Role | Group |
|---|---|---|
Michael Cho | CEO | Leadership |
Complete people profiles for Dana Solutions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Dana Solutions
2 dated milestones of Dana Solutions across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Dana Solutions is founded.
- Exit Acquired by Curi Bio.
Competitors of Dana Solutions
Dana Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, Certara, HotSpot Therapeutics, CytoReason and GRO Biosciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insitro.com | 2018 | San Francisco, United States | $643.21M | 257 | An AI-enabled platform is developed for infectious disease treatment. | |
| certara.com | 2008 | Princeton, United States | – | 827 | Provider of a platform for in silico drug discovery and consulting services | |
| hotspotthera.com | 2017 | Boston, United States | $210M | 37 | Developer of a platform for protein function analysis | |
| cytoreason.com | 2016 | Haifa, Israel | $100M | – | Immune system-based drugs are discovered via biological data analytics. | |
| grobio.com | 2016 | Boston, United States | $91.15M | 22 | Synthetic biology tools are developed via genetic code recoding techniques. | |
| tolremo.com | 2017 | Zurich, Switzerland | $55.81M | – | Anti-cancer small molecules are developed to target drug resistance pathways. | |
| inpharmatica.co.uk | 1998 | London, United Kingdom | – | 62 | Developer of predictive informatics based platform for drug discovery | |
| recludixpharma.com | 2020 | San Diego, United States | $60M | 33 | Provider of the online platform for drug discovery and development | |
| postera.ai | 2019 | London, United Kingdom | $26.2M | 3 | AI based molecular designing software for drug discovery | |
| cartography.bio | 2020 | Foster, United States | $124M | 10 | Provider of a platform to discover immunotherapeutics |
Detailed competitors of Dana Solutions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Dana Solutions
10 companies that operate in the same segment as Dana Solutions (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dana Solutions
Dana Solutions was founded in 2018.
Dana Solutions is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Michael Cho is the current CEO of Dana Solutions.
Dana Solutions was founded in 2018 in Palo Alto, United States, focusing on biotechnology through AI-based platforms. Cellular and tissue analytics are enabled by PhenoLearn, while contractility analysis of cardiomyocytes is handled by Pulse. In vitro structural toxicity testing is conducted via PhenoTox. Operations center on these specialized tools for research and testing applications.
Dana Solutions's top competitors include Insitro, HotSpot Therapeutics and Certara.
Dana Solutions has 1 investor. Key investors include Curi Bio.
Yes. Dana Solutions was acquired by Curi Bio in July 2020.